Dr. Miller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2845 Greenbrier Rd
1st Floor
Green Bay, WI 54311Phone+1 920-288-8100
Education & Training
- University of Wisconsin Hospitals and ClinicsFellowship, Infectious Disease, 1998 - 2000
- Johns Hopkins UniversityResidency, Internal Medicine, 1996 - 1998
- Mayo ClinicPhD, Immunology, 1990 - 1996
- Mayo Clinic College of MedicineClass of 1996
- University of Wisconsin-MadisonBS, Biochemistry and Molecular Biology, with Distinction, 1987 - 1989
- University of Wisconsin Center-Rock CountyAS, Science, 1984 - 1986
Certifications & Licensure
- MI State Medical License 2003 - 2025
- WI State Medical License 1998 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
- Elected American Society for Clinical Investigation (ASCI), 2012
- Jerome W. Conn Award for Excellence in Research University of Michigan Department of Internal Medicine, 2009
- Join now to see all
Publications & Presentations
PubMed
- 22 citationsOptimization of Novel Indole-2-carboxamide Inhibitors of Neurotropic Alphavirus ReplicationJanice A. Sindac, Scott J. Barraza, Craig J. Dobry, Jianming Xiang, Pennelope K. Blakely
Journal of Medicinal Chemistry. 2013-11-27 - 97 citationsHeat Shock Proteins Regulatory Role in Neurodevelopment.David J. Miller, Patrice Fort
Frontiers in Neuroscience. 2018-11-12 - 19 citationsActivation of the type I interferon pathway is enhanced in response to human neuronal differentiation.Jocelyn R. Farmer, Kate M. Altschaefl, K. Sue O'Shea, David J. Miller
Plos One. 2013-03-07
Journal Articles
- The Combined Use of Alphavirus Replicons and Pseudoinfectious Particles for the Discovery of Antivirals Derived from Natural ProductsDelekta, P.C., Raveh, A., Larsen, M.J., Sherman, D.H., and Miller, D.J., J. Biomolec. Screen, 1/1/2015
- Discovery of Anthranilamides as a Novel Class of Inhibitors of Neurotropic Alphavirus ReplicationBarraza, S.J., Delekta, P.C., Sindac, J.A., Dobry, C.J., Xiang, J., Kirchhoff, P.D., Keep, R.F., Miller, D.J., and Larsen, S.D., Bioorg. Med. Chem, 1/1/2015
- Manipulation of Host Factors Optimizes the Pathogenesis of Western Equine Encephalitis Virus Infections in Mice for Antiviral Drug DevelopmentBlakely, P.K., Delekta, P.C., Miller, D.J., and Irani, D.N., J. Neurovirol, 1/1/2015
- Join now to see all
Books/Book Chapters
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: